ResearchDx, the leading Contract Diagnostics Organization, expands operations into the Middle East

Dubai, United Arab Emirates - Monday, January 27th 2014 [ME NewsWire]

(BUSINESS WIRE)-- ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets.
As part of this initiative, ResearchDx will be exhibiting at the 2014 Arab Health Congress in Dubai, UAE, held January 27th-30th, at the Dubai International Convention and Exhibition Centre. “We are proud to be involved as an exhibitor at Arab Health” said Dr. Mathew Moore, Co-Founder and Principal at ResearchDx.
ResearchDx provides comprehensive services to assist International Clinical Laboratories obtain Clinical Laboratory licensure and accreditations, such as ISO15189, College of American Pathologists (CAP) accreditation and US International CLIA certification. “Internationally recognized clinical laboratory accreditations provide our clients with a competitive edge. These accreditations and licensures have enabled our clients to successfully compete for multi-national based clinical trial studies and demonstrate the internationally recognized quality of their laboratories” said Dr. Philip Cotter, Principal and Co-Founder of ResearchDx
“In addition, as the leading Contract Diagnostics Organization, ResearchDx can provide strategic partnerships to Middle Eastern biopharmaceutical and diagnostic companies looking to develop companion diagnostics or in vitrodiagnostic products for the local, US or European markets. We provide a full range of companion diagnostics and in vitro diagnostics services” said Dr. Mathew Moore.
ResearchDx is the leading Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, through a complete set of clinical research services and on to regulatory approval, ResearchDx offers the services and solutions to meet complex diagnostics development needs. ResearchDx’s primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and clinical laboratory consulting. Additional information is available at www.researchdx.com.

---

Contacts

Philip D. Cotter, PhD, FACMG, FFSc(RCPA)
ResearchDx
5 Mason, Suite 100
Irvine, CA 92618
pcotter@researchdx.com
866-225-9195 / 510-332-0477

---

Permalink: http://me-newswire.net/news/9834/en